Skip to main content
. 2017 Spring;16(2):834–846.

Table 7.

Related weight of sub-criteria of tangible assets

Sub-criteria
of
Tangible assets
Relative weight of Main criteria matrix (%)
In
generic
pharmaceutical industry
CR Relative weight of Main criteria matrix (%)
In
bio-generic
pharmaceutical industry
CR
Production facility 0.262 .030 0.240 .007
Testing facility 0.166 0.250
personnel 0.139 0.202
R&D investment 0.434 0.308